Sheel Patel
About Sheel Patel
Sheel Patel is a Senior Manager in Clinical Science at BeiGene with a background in pharmacy and extensive experience in clinical research and drug development.
Current Position at BeiGene
Sheel Patel is currently serving as the Senior Manager of Clinical Science at BeiGene, starting in June 2021. In this role, Sheel contributes to clinical science operations, utilizing in-depth knowledge and experience in drug development and clinical research.
Past Experience at PPD
Before joining BeiGene, Sheel Patel worked at PPD as a Drug Development and Clinical Research Fellow from 2020 to 2021. During this 10-month fellowship, Sheel gained valuable experience in clinical research protocols and drug development processes, enhancing skills essential for managing clinical science in pharmaceutical environments.
Fellowship at University of North Carolina at Chapel Hill
Sheel Patel completed a two-year fellowship in Clinical Research and Drug Development at the University of North Carolina at Chapel Hill from 2019 to 2021. This role provided Sheel with a solid foundation in clinical trials and research methodologies, contributing significantly to their expertise in the field.
Education in Pharmacy at University of the Pacific
Sheel Patel earned a Doctor of Pharmacy (PharmD) degree from the University of the Pacific, where they studied from 2016 to 2019. This comprehensive education in pharmacy laid the groundwork for Sheel’s career in clinical research and pharmaceutical sciences.
Leadership Roles and Research Projects
Throughout their career, Sheel Patel has held numerous leadership roles and led several research projects. Notable positions include President of the Phi Lambda Sigma Rho Chapter, Vice President of the Student Body Government at the Thomas J Long School of Pharmacy & Health Sciences, and Project Manager for the Veterans Service Project. Additionally, Sheel conducted a cross-sectional study investigating student-led health initiatives and served as Associate Investigator for The Hangover Secret Pilot Study.